Your browser doesn't support javascript.
loading
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population.
Dipasquale, Valeria; Alibrandi, Angela; Pellegrino, Salvatore; Ramistella, Vincenzo; Romano, Claudio.
Affiliation
  • Dipasquale V; Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
  • Alibrandi A; Statistical and Mathematical Sciences Unit, Department of Economics, University of Messina, Messina, Italy.
  • Pellegrino S; Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
  • Ramistella V; Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
  • Romano C; Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Expert Rev Clin Immunol ; 20(2): 237-244, 2024 02.
Article in En | MEDLINE | ID: mdl-37962991
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Biosimilar Pharmaceuticals Limits: Child / Female / Humans Language: En Journal: Expert Rev Clin Immunol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Biosimilar Pharmaceuticals Limits: Child / Female / Humans Language: En Journal: Expert Rev Clin Immunol Year: 2024 Document type: Article